[Intraepithelial punctate superficial keratitis following oral drug administration].
D000284:Administration, Oral; D000447:Aldehydes / Q000009:adverse effects*; D007634:Keratitis; D007637:Keratoconjunctivitis; D009525:Niacin; D009539:Nicotinic Acids / Q000009:adverse effects*; D013882:Thiosemicarbazones / Q000009:adverse effects*
D000447:Aldehydes; D009539:Nicotinic Acids; D013882:Thiosemicarbazones; D009525:Niacin
ALDEHYDES/injurious effects; KERATITIS; NICOTINIC ACID ISOMERS/injurious effects; THIOSEMICARBAZONES/injurious effects
Keratitis superficialis punctata intraepithelialis nach enteraler Arzneimittelverabreichung.